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aBstraCt
Retinoma (or retinocytoma) is a rare benign intraocular tumor with characteristic features and can be diagnosed 
clinically. In this article, we present a case report and a review of literature about retinoma. The case is about an 
incidentally diagnosed retinoma in an asymptomatic young female who presented for vision checkup and was found 
to have an intraocular translucent-grey, elevated mass extending into the vitreous cavity from the retina with the 
characteristic features of retinoma. The main differential diagnosis included retinoblastoma and astrocytic hamar-
toma. The mass showed no growth over a period of 6 months of follow up with colored fundus photography and 
ultrasound. This case is, to the best of our knowledge, the first case of retinoma diagnosed in Jordan. 
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introduCtion
Retinoma is a retinal tumor that is highly associ-
ated with retinoblastoma, but lacking malignant 
characteristics, that has been inaccurately initially 
considered as ‘‘spontaneous regression’’ of retino-
blastoma [1]. However, clinical evidences do not 
support this hypothesis and suggest that retinoma 
rather represents a step towards retinoblastoma de-
velopment [1–6]. Dimaras and colleagues demon-
strated that retinomas display inactivation of both 
RB1 alleles, absence of proliferative markers, low 
level of genomic instability and high expression of 
the senescence-associated proteins; while retinoblas-
tomas, on the other hand, show reduced expression 
of senescence-associated proteins and increased ge-
nomic changes, indicating progression from retin-
oma; which means that retinoma started from the 
beginning as retinoma, with the possibility to stay 
stable as retinoma, or rarely convert to retinoblas-
toma [7]. 
Case report 
A 30-year-old female patient was referred to our 
center because of an intraocular retinal mass. The pa-
tient was asymptomatic and was incidentally found 
to have this lesion during a routine vision examina-
tion by another ophthalmologist. On examination, 
best corrected visual acuity was 6/6 in both eyes, an-
terior segment examination was within normal lim-
its and intraocular pressure was 14 mm Hg in both 
eyes. Fundus examination of the left eye was normal 
while that of the right eye revealed an intraocular 
endophytic translucent retinal mass (Fig. 1) which 
was located in the superionasal quadrant protruding 
toward the vitreous cavity, surrounded by areas of 
chorioretinal atrophy and few spots of retinal pig-
ment hyperplasia. The lesion has a cottage-cheese 
like appearance resembling post-radiation treated 
retinoblastoma. B-scan ultrasonography (Fig. 2) 
revealed hyperechoic lesion with high internal re-
flectivity and dense orbital shadowing consistent 
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with calcification inside the tumor. The patient was 
followed up over a period of 6 months by colored 
fundus photography and B-scan ultrasonography, 
which showed no growth and verified our diagnosis. 
disCussion 
Retinoma is a rare benign tumor with incidence 
among retinoblastoma patients ranging between 
1.8% and 15.6 % [5–7]. The disease is usually 
asymptomatic and may be diagnosed sporadically 
in a patient with retinoblastoma in the same eye, 
retinoblastoma in the other eye, or retinoblastoma 
in the family member [5, 6].
Margo et al. studied retinomas by light and 
electron microscopy and tested them with certain 
tissue markers and reported that these small pla-
coid, noninvasive lesions were composed entirely of 
Figure 2. B-scan ultrasonography of the right eye with retinoma
Figure 1. Color fundus photography of the right eye with retinoma
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benign-appearing cells with numerous fleurettes and 
showed no necrosis or mitotic activity. Ultrastructur-
ally, they were composed predominantly of neuronal 
cells exhibiting photoreceptor differentiation [4].
Ophthalmoscopically, these tumors are character-
ized by translucent mass, calcification, chorioretinal 
atrophy, and retinal pigment epithelium changes [1, 
6, 8]. Calcified vitreous deposits is a recently described 
feature of retinoma in addition to the four classical 
features [9]. It was noted that up to 4% of retinomas 
may undergo benign cystic enlargement, which might 
be associated with an aggressive tumor potential [10].
Despite the characteristic ophthalmoscopic 
features mentioned above, certain entities, such 
as retinoblastoma and astrocytic hamartoma, can 
closely resemble retinoma. Retinoblastoma is usu-
ally diagnosed before the age of 5 and retinoma is 
usually diagnosed in adults. Although calcification 
is seen in both tumors, areas of chorioretinal atro-
phy and associated retinal pigment epithelial chang-
es are uncommon in untreated retinoblastoma. In 
addition, dilated, tortuous retinal feeder vessels are 
a feature of retinoblastoma rather than retinoma. 
Characteristically, retinoblastoma will show growth 
within 4–6 weeks, whereas retinoma will appear 
unchanged. Astrocytic hamartoma is a benign reti-
nal tumor and can also closely resemble retinoma 
because both lesions may be calcified. Calcification, 
when present, can demonstrate subtle differences, 
as it tends to be dull and chalky white in retinoma, 
whereas in astrocytoma it is more glistening yellow, 
resembling fish eggs. Surrounding retinal pigment 
epithelium alterations, a common finding in retin-
oma, is typically absent in astrocytic hamartoma as 
they are situated superficially in the retina [11].
Malignant transformation into retinoblastoma 
is rare [3, 5], although a new study reported higher 
transformation rate that might reach up to 12% 
[10]. In the unfortunate event that malignant trans-
formation occurs, systemic chemotherapy combined 
with consolidation focal therapy has become the 
standard treatment for retinoblastoma [12], with 
external beam radiation as a less favored treatment 
option [13]. The incidence of second malignant ne-
oplasms in RB1 gene mutation carriers with retino-
cytoma is unknown, but well documented [10].
Retinoma is considered a rare phenotype of 
RB1 gene mutation and carries the same genetic 
implication as retinoblastoma [14]. The exact reason 
of why some patients develop retinoma rather than 
retinoblastoma is not yet known, but hypothetically 
it may arise if the second hit occurred in a later stage 
of cell maturation when the precursor cell has a lim-
ited mitotic capability and is unable to accumulate 
further mutations [15].
Studies aimed at clarifying retinoma/retinoblas-
toma relationship at molecular level are rarely per-
formed. This is principally due to the fact that retin-
oma tissue is very difficult to obtain since patients 
are not treated and retinoma/retinoblastoma mixed 
tissues are rarely reported in enucleated eyes [2]. 
However, from the few reported cases, which have 
been dissected and analyzed, it turned out that from 
genetic point of view, retinoma should be considered 
as retinoblastoma with autosomal dominant inherit-
ance pattern involving a mutation in the RB1 gene 
locus on chromosome 13q14 [1, 2]. The diagnosis of 
retinoma strongly suggests the presence of the retin-
oblastoma gene, necessitating genetic counseling and 
frequent observation of the retinas in the individual 
and his offspring [1, 2]. We suggest that the same 
mutations can cause either retinoma or retinoblas-
toma: benign hyperplastic nodules or retinoma when 
the mutations occur in relatively mature retinoblasts; 
and malignant retinoblastoma when the same muta-
tions arise in immature retinoblasts [1].
Although retinoblastoma is a well-known tumor 
in Jordan and the reported epidemiological data in-
dicates that the incidence of retinoblastoma in Jor-
dan is similar to that reported in various countries 
of the world [16], this is the first case of retinoma 
diagnosed in Jordan. 
ConClusions  
It is of paramount importance to diagnose retin-
oma and differentiate it from retinoblastoma be-
cause the management plan for both is completely 
different; retinoblastoma necessitates urgent treat-
ment while retinoma needs only observation. Nev-
ertheless, these patients should be monitored for life 
because of the small risk of malignant transforma-
tion or associated second malignant neoplasms 
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